Amicus Therapeutics (FOLD) 7.50 $FOLD
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
PR Newswire - Fri Oct 30, 1:40PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FOLD: 7.50 (-0.06)
INVESTOR ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Amicus Therapeutics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- FOLD
GlobeNewswire - Thu Oct 29, 5:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Amicus Therapeutics, Inc. (Nasdaq:FOLD) ("Amicus" or the "Company"
common stock during the period between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 7, 2015 to seek appointment as lead plaintiff.
FOLD: 7.50 (-0.06)
BUYINS.NET: FOLD SqueezeTrigger Price is $7.50. There is $125,638,795 That Short Sellers Still Need To Cover.
M2 - Thu Oct 29, 11:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Amicus Therapeutics Inc (NASDAQ:FOLD) in real time and just received an alert that FOLD is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 16640900 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $7.50. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
FOLD: 7.50 (-0.06)
5 Biotech Stocks Under $10 Triggering Breakout Trades
at The Street - Wed Oct 28, 6:03AM CDT
Keep these under-$10 biotech stocks on your breakout trading radar.
TTPH: 9.03 (+0.02), VTL: 7.77 (-0.72), AAVL: 8.43 (-0.03), FOLD: 7.50 (-0.06), OCUL: 8.63 (-0.75)
Amicus Therapeutics to Announce Third Quarter 2015 Financial Results on November 3, 2015
GlobeNewswire - Tue Oct 27, 3:01PM CDT
Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Tuesday, November 3, 2015 at 4:30 p.m. ET to discuss financial results for the third quarter ended September 30, 2015.
FOLD: 7.50 (-0.06)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Amicus Therapeutics, Inc. Investors
Business Wire - Mon Oct 26, 12:10PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Amicus Therapeutics, Inc. ("Amicus" or the "Company" (Nasdaq: FOLD) between September 15, 2015 through October 1, 2015, both dates inclusive. The lawsuit concerns losses sustained by Amicus investors after recent Company announcements regarding delays in submitting a New Drug Application ("NDA" to the Food and Drug Administration ("FDA" . Investors who suffered losses on their investment in Amicus securities are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action.
FOLD: 7.50 (-0.06)
Downtrend Call Working As Amicus Therapeutics Stock Falls 55.7% (FOLD)
Comtex SmarTrend(R) - Fri Oct 23, 5:22PM CDT
SmarTrend identified a Downtrend for Amicus Therapeutics (NASDAQ:FOLD) on September 24th, 2015 at $14.89. In approximately 4 weeks, Amicus Therapeutics has returned 55.74% as of today's recent price of $6.59.
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Amicus Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FOLD
GlobeNewswire - Fri Oct 23, 2:26PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company" (NASDAQ:FOLD) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased Amicus securities between September 15, 2015 and October 1, 2015 inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
FOLD: 7.50 (-0.06)
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Amicus Therapeutics, Inc. And Encourages Shareholders To Contact The Firm
Business Wire - Thu Oct 22, 12:40PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed in United States District court, District of New Jersey, against Amicus Therapeutics, Inc. ("Amicus" or the "Company" (NASDAQ: FOLD), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" , have until December 7, 2015 to file a motion to be appointed as lead plaintiff.
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
GlobeNewswire - Thu Oct 22, 9:03AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Amicus Therapeutics, Inc. And Encourages Investors To Contact The Firm
Business Wire - Wed Oct 21, 10:50PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company" (FOLD). Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" are encouraged to contact the Firm immediately to discuss their legal options.
FOLD: 7.50 (-0.06)
TRADING ALERT: Rosen Law Firm Reminds Amicus Therapeutics, Inc. Investors of Important Deadline in Class Action - FOLD
Business Wire - Wed Oct 21, 1:12PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Amicus Therapeutics, Inc. (NASDAQ:FOLD) securities during the period from September 15, 2015 through October 1, 2015, inclusive (the "Class Period" , of the important December 7, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Amicus Therapeutics investors under the federal securities laws.
FOLD: 7.50 (-0.06)
INVESTOR ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Amicus Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Fri Oct 16, 9:35PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Amicus Therapeutics, Inc. (Nasdaq: FOLD) ("Amicus" or the "Company" common stock during the period between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 7, 2015 to seek appointment as lead plaintiff.
FOLD: 7.50 (-0.06)
IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a Class Action Lawsuit Has Been Filed Against Amicus Therapeutics, Inc. in the United States District Court for the District of New Jersey - FOLD
GlobeNewswire - Fri Oct 16, 6:00PM CDT
Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been commenced against Amicus Therapeutics, Inc. ("Amicus" or "Company" (NASDAQ:FOLD) in the United States District Court for the District of New Jersey, on behalf of all persons who purchased Amicus common stock on the open market or pursuant to the Secondary Public Offering ("SPO" on June 11, 2015, during the period March 19, 2015 through October 1, 2015, inclusive. Shareholders of Amicus Therapeutics, Inc. who incurred losses on shares purchased within the Class Period are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
FOLD: 7.50 (-0.06)
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Amicus Therapeutics, Inc.
PR Newswire - Fri Oct 16, 5:30PM CDT
Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of persons who purchased or acquired the shares of Amicus Therapeutics, Inc. ("Amicus" or the "Company" (NASDAQ: FOLD) between September 15, 2015 and October 1, 2015 inclusive (the "Class Period" .
FOLD: 7.50 (-0.06)
51.6% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Fri Oct 16, 11:47AM CDT
SmarTrend identified a Downtrend for Amicus Therapeutics (NASDAQ:FOLD) on September 24th, 2015 at $14.89. In approximately 3 weeks, Amicus Therapeutics has returned 51.65% as of today's recent price of $7.20.
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Amicus Therapeutics, Inc. and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
GlobeNewswire - Thu Oct 15, 5:02PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Amicus Therapeutics, Inc. (NASDAQ:FOLD) securities between March 19, 2015 and October 1, 2015.
FOLD: 7.50 (-0.06)
3 Biotech Stocks Under $10 to Buy for Breakout Gains
at The Street - Thu Oct 15, 12:25PM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.
AFMD: 6.34 (-0.11), LBIO: 6.47 (-0.14), FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Amicus Therapeutics, Inc. and Encourages Investors to Contact the Firm
Business Wire - Wed Oct 14, 8:24PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company" (NASDAQ: FOLD). Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" are encouraged to contact the Firm immediately to discuss their legal options.
FOLD: 7.50 (-0.06)
Amicus Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
Business Wire - Wed Oct 14, 12:21PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court, District of New Jersey against Amicus Therapeutics, Inc. ("Amicus" (NasdaqGM: FOLD) and several officers and directors for acts taken during the period of September 15, 2015 and October 1, 2015 (the "Class Period" .
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
PR Newswire - Fri Oct 30, 1:40PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FOLD: 7.50 (-0.06)
INVESTOR ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Amicus Therapeutics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- FOLD
GlobeNewswire - Thu Oct 29, 5:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Amicus Therapeutics, Inc. (Nasdaq:FOLD) ("Amicus" or the "Company"
common stock during the period between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 7, 2015 to seek appointment as lead plaintiff. FOLD: 7.50 (-0.06)
BUYINS.NET: FOLD SqueezeTrigger Price is $7.50. There is $125,638,795 That Short Sellers Still Need To Cover.
M2 - Thu Oct 29, 11:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Amicus Therapeutics Inc (NASDAQ:FOLD) in real time and just received an alert that FOLD is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 16640900 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $7.50. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
FOLD: 7.50 (-0.06)
5 Biotech Stocks Under $10 Triggering Breakout Trades
at The Street - Wed Oct 28, 6:03AM CDT
Keep these under-$10 biotech stocks on your breakout trading radar.
TTPH: 9.03 (+0.02), VTL: 7.77 (-0.72), AAVL: 8.43 (-0.03), FOLD: 7.50 (-0.06), OCUL: 8.63 (-0.75)
Amicus Therapeutics to Announce Third Quarter 2015 Financial Results on November 3, 2015
GlobeNewswire - Tue Oct 27, 3:01PM CDT
Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Tuesday, November 3, 2015 at 4:30 p.m. ET to discuss financial results for the third quarter ended September 30, 2015.
FOLD: 7.50 (-0.06)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Amicus Therapeutics, Inc. Investors
Business Wire - Mon Oct 26, 12:10PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Amicus Therapeutics, Inc. ("Amicus" or the "Company"
(Nasdaq: FOLD) between September 15, 2015 through October 1, 2015, both dates inclusive. The lawsuit concerns losses sustained by Amicus investors after recent Company announcements regarding delays in submitting a New Drug Application ("NDA" to the Food and Drug Administration ("FDA" . Investors who suffered losses on their investment in Amicus securities are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action. FOLD: 7.50 (-0.06)
Downtrend Call Working As Amicus Therapeutics Stock Falls 55.7% (FOLD)
Comtex SmarTrend(R) - Fri Oct 23, 5:22PM CDT
SmarTrend identified a Downtrend for Amicus Therapeutics (NASDAQ:FOLD) on September 24th, 2015 at $14.89. In approximately 4 weeks, Amicus Therapeutics has returned 55.74% as of today's recent price of $6.59.
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Amicus Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FOLD
GlobeNewswire - Fri Oct 23, 2:26PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company"
(NASDAQ:FOLD) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased Amicus securities between September 15, 2015 and October 1, 2015 inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" . FOLD: 7.50 (-0.06)
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Amicus Therapeutics, Inc. And Encourages Shareholders To Contact The Firm
Business Wire - Thu Oct 22, 12:40PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed in United States District court, District of New Jersey, against Amicus Therapeutics, Inc. ("Amicus" or the "Company"
(NASDAQ: FOLD), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" , have until December 7, 2015 to file a motion to be appointed as lead plaintiff. FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
GlobeNewswire - Thu Oct 22, 9:03AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Amicus Therapeutics, Inc. And Encourages Investors To Contact The Firm
Business Wire - Wed Oct 21, 10:50PM CDT
Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company" (FOLD). Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" are encouraged to contact the Firm immediately to discuss their legal options. FOLD: 7.50 (-0.06)
TRADING ALERT: Rosen Law Firm Reminds Amicus Therapeutics, Inc. Investors of Important Deadline in Class Action - FOLD
Business Wire - Wed Oct 21, 1:12PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Amicus Therapeutics, Inc. (NASDAQ:FOLD) securities during the period from September 15, 2015 through October 1, 2015, inclusive (the "Class Period"
, of the important December 7, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Amicus Therapeutics investors under the federal securities laws. FOLD: 7.50 (-0.06)
INVESTOR ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Amicus Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Fri Oct 16, 9:35PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Amicus Therapeutics, Inc. (Nasdaq: FOLD) ("Amicus" or the "Company"
common stock during the period between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 7, 2015 to seek appointment as lead plaintiff. FOLD: 7.50 (-0.06)
IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a Class Action Lawsuit Has Been Filed Against Amicus Therapeutics, Inc. in the United States District Court for the District of New Jersey - FOLD
GlobeNewswire - Fri Oct 16, 6:00PM CDT
Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been commenced against Amicus Therapeutics, Inc. ("Amicus" or "Company"
(NASDAQ:FOLD) in the United States District Court for the District of New Jersey, on behalf of all persons who purchased Amicus common stock on the open market or pursuant to the Secondary Public Offering ("SPO" on June 11, 2015, during the period March 19, 2015 through October 1, 2015, inclusive. Shareholders of Amicus Therapeutics, Inc. who incurred losses on shares purchased within the Class Period are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. FOLD: 7.50 (-0.06)
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Amicus Therapeutics, Inc.
PR Newswire - Fri Oct 16, 5:30PM CDT
Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of persons who purchased or acquired the shares of Amicus Therapeutics, Inc. ("Amicus" or the "Company"
(NASDAQ: FOLD) between September 15, 2015 and October 1, 2015 inclusive (the "Class Period" . FOLD: 7.50 (-0.06)
51.6% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Fri Oct 16, 11:47AM CDT
SmarTrend identified a Downtrend for Amicus Therapeutics (NASDAQ:FOLD) on September 24th, 2015 at $14.89. In approximately 3 weeks, Amicus Therapeutics has returned 51.65% as of today's recent price of $7.20.
FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Amicus Therapeutics, Inc. and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
GlobeNewswire - Thu Oct 15, 5:02PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Amicus Therapeutics, Inc. (NASDAQ:FOLD) securities between March 19, 2015 and October 1, 2015.
FOLD: 7.50 (-0.06)
3 Biotech Stocks Under $10 to Buy for Breakout Gains
at The Street - Thu Oct 15, 12:25PM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.
AFMD: 6.34 (-0.11), LBIO: 6.47 (-0.14), FOLD: 7.50 (-0.06)
SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Amicus Therapeutics, Inc. and Encourages Investors to Contact the Firm
Business Wire - Wed Oct 14, 8:24PM CDT
Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company" (NASDAQ: FOLD). Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the "Class Period" are encouraged to contact the Firm immediately to discuss their legal options. FOLD: 7.50 (-0.06)
Amicus Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
Business Wire - Wed Oct 14, 12:21PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court, District of New Jersey against Amicus Therapeutics, Inc. ("Amicus"
(NasdaqGM: FOLD) and several officers and directors for acts taken during the period of September 15, 2015 and October 1, 2015 (the "Class Period" . FOLD: 7.50 (-0.06)
